These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

792 related items for PubMed ID: 6304810

  • 41. Novel method for quantitative evaluation of cardiac amyloidosis using (201)TlCl and (99m)Tc-PYP SPECT.
    Yamamoto Y, Onoguchi M, Haramoto M, Kodani N, Komatsu A, Kitagaki H, Tanabe K.
    Ann Nucl Med; 2012 Oct; 26(8):634-43. PubMed ID: 22777859
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Non-invasive detection and differentiation of cardiac amyloidosis using 99mTc-pyrophosphate scintigraphy and 11C-Pittsburgh compound B PET imaging.
    Takasone K, Katoh N, Takahashi Y, Abe R, Ezawa N, Yoshinaga T, Yanagisawa S, Yazaki M, Oguchi K, Koyama J, Sekijima Y.
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement.
    Miller EJ, Campisi R, Shah NR, McMahon S, Cuddy S, Gallegos-Kattan C, Maurer MS, Damy T, Slart RHJA, Bhatia K, Einstein AJ.
    J Nucl Cardiol; 2022 Oct; 29(5):2748-2760. PubMed ID: 35838892
    [No Abstract] [Full Text] [Related]

  • 48. Primary amyloid heart disease presenting as hypertrophic obstructive cardiomyopathy.
    Weston LT, Raybuck BD, Robinowitz M, Brinker JA, Oetgen WJ.
    Cathet Cardiovasc Diagn; 1986 Oct; 12(3):176-81. PubMed ID: 3015411
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. CT, MR imaging, and radionuclide imaging in a patient with hepatic involvement in primary amyloidosis.
    Ohta H, Kokuryu H, Ota T, Tomono N, Shimizu T, Shintaku M, Komibuchi T.
    Clin Nucl Med; 1997 Nov; 22(11):778-80. PubMed ID: 9363391
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Amyloid goiter: preoperative scintigraphic diagnosis using Tc-99m pyrophosphate.
    Lee VW, Rubinow A, Pehrson J, Skinner M, Cohen AS.
    J Nucl Med; 1984 Apr; 25(4):468-71. PubMed ID: 6100548
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Technetium 99m-pyrophosphate scintigraphy in amyloid cardiomyopathy.
    Ptacin MJ, Bamrah V, Duthie E.
    Wis Med J; 1985 Mar; 84(3):25-7. PubMed ID: 2986368
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.